Merck lifts full-year forecast as Keytruda sales soar

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. TSLA
4. NVDA
5. GNK
6. USO
7. AWK
8. ARGX
9. AZN
10. SPCX

Go back to Merck lifts full-year forecast as Keytruda sales soar
Merck & Co. (NYSE: MRK) Delayed: 135.97 +0.13 (0.10%)
Previous Close $135.84    52 Week High $65.46 
Open $134.95    52 Week Low $47.97 
Day High $137.17    P/E 92.50 
Day Low $134.55    EPS $1.47 
Volume 8,477,294